For the first time, a clinical trial will rigorously examine the addiction potential of kratom, a popular herbal supplement used by millions of Americans for pain relief and mental health support. The study, led by researchers at Baylor College of Medicine, will compare kratom’s effects to those of the opioid oxycodone to determine whether it poses significant risks or holds therapeutic promise.
Kratom, derived from a Southeast Asian tree, is widely available in forms like pills and drinks, often sold in vape shops or online. While many users praise its ability to alleviate pain and opioid cravings, concerns about addiction and overdose—particularly at high doses—have prompted calls for stricter regulation.
The findings from this trial could shape future policies and help clarify whether kratom is a safe alternative or requires tighter oversight. For more details, visit the original article on the Union Leader website.
